Device Trial Radar · NCT04932486
Transcutaneous Electrical Stimulation in Obstructive Sleep Apnea
Last checked: Nov 20, 2026Latest source record: Apr 14, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
42
Actual
Start
May 26, 2021
Primary completion
Apr 13, 2023
Study completion Apr 13, 2023
Sponsor
- Lead sponsor
- SunriseNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 21, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this study is to assess the efficacy of transcutaneous electrical stimulation of the upper airway muscles in patients with obstructive sleep apnea.
Conditions
- Obstructive Sleep Apnea
Interventions
Transcutaneous electrical stimulationDevice
Transcutaneous electrical stimulation of the upper airway muscles
Primary outcomes
What the sponsor says the trial is designed to measure.
- Apnea-hypopnea index (AHI)Time frame: 6 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Respisom
Namur, Belgium
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.